2 Top Biotech Stocks to Buy Under $10
- ByStockNews-
The COVID-19 pandemic brought renewed interest in the biotech industry. Many company's that weren't even working on vaccines or treatments saw their shares rise. But there are also...
The COVID-19 pandemic brought renewed interest in the biotech industry. Many company's that weren't even working on vaccines or treatments saw their shares rise. But there are also...
Because the spread of the coronavirus Delta variant in several countries is becoming a major concern, the biotech industry is expected to continue attracting investors’...
Investing.com – U.S. stocks were lower after the close on Wednesday, as losses in the Technology, Healthcare and Consumer Services sectors led shares lower. At the close in NYSE,...
1.Allied Healthcare ProductsAllied Healthcare Products (NASDAQ:AHPI) popped, pulled back, reversed on Tuesday, and on Wednesday it followed through, jumping 1.54, or 13%, to...
1. Altimmune (NASDAQ:ALT) exploded on Tuesday. When it broke out of the wedge a week ago, I showed you the pop and said this stock may not be done yet. It went from 3.00 to...
Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) have surged significantly in the year so far. The stock has skyrocketed 118.2% against the industry’s decline of...
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Buy | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 618.35 | 622.22 | 594.53 | +6.84 | +1.12% | 1.07M | NYSE | |||
| 17.99 | 18.82 | 17.84 | -1.55 | -7.93% | 6.37M | NASDAQ | |||
| 74.67 | 74.92 | 72.17 | +2.12 | +2.92% | 11.09M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 8.24 | 8.39 | 8.00 | -0.00 | -0.05% | 6.20M | NYSE | |||
| 0.208 | 0.208 | 0.183 | +0.0250 | +13.66% | 1.29M | NYSE | |||
| 38.76 | 39.12 | 38.31 | -0.66 | -1.67% | 7.42M | NYSE | |||
| 1.13 | 1.135 | 1.09 | -0.0300 | -2.59% | 5.36M | NYSE | |||
| 30.57 | 30.64 | 29.97 | +0.18 | +0.59% | 3.88M | NYSE | |||
| 2.73 | 2.895 | 2.58 | -0.020 | -0.73% | 336.06K | NASDAQ | |||
| 2,050.06 | 2,094.74 | 2,019.34 | -56.59 | -2.69% | 337.45K | NASDAQ | |||
| 7.81 | 8.29 | 7.51 | -0.52 | -6.24% | 5.13M | NASDAQ | |||
| 2.38 | 2.895 | 2.335 | -0.570 | -19.32% | 9.94M | NYSE | |||
| 9.15 | 10.479 | 8.47 | -1.680 | -15.51% | 25.92M | NASDAQ | |||
| 57.49 | 57.51 | 57.48 | 0.00 | 0.00% | 0.00 | NASDAQ |